Psycometric Properties of Pushing Scale

Sponsor
Guadarrama Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03674268
Collaborator
Universidad Francisco de Vitoria (Other)
120
1
15.9
7.6

Study Details

Study Description

Brief Summary

Psycometric properties of a scale

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Management of the Contraversive Pushing Scale

Detailed Description

After a period of training in the administration of the CPS, a pilot will be conducted with 10 patients who meet the inclusion-exclusion criteria and after signing the informed consent document, in which the 4 researchers will administer the CPS during two sessions on consecutive days, with the objective of evaluating the test-retest and intra-observer reliability, minimize the differences of criteria in its application and, if necessary, write an instruction manual.

Once each patient has signed the informed consent document and it has been verified that the inclusion criteria are met, it will be assigned an Identification Number (ID) that will relate it to your Medical Record (IDHC) by simple coding; The custody of the file with the relation of each ID with its HC will be borne by the principal investigator. Likewise, each observer will be assigned an identification number in order to blind the researcher who performs the statistical analysis. The patients included in the study will be evaluated, through the Spanish version of the CPS, by two of the researchers with an interval of 10 minutes between each evaluation, repeating this same procedure the next day. These evaluation sessions will be carried out throughout the treatment period, repeating on days 1, 15 and 28 of the period of admission of the included patients. Two researchers will evaluate the patients treated in the morning shift and the other two those treated in the afternoon shift of the Physiotherapy Service of the Guadarrama Hospital.

Study Design

Study Type:
Observational
Actual Enrollment :
120 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Psychometric Properties of the Spanish Version of the Contraversive Pushing Scale
Actual Study Start Date :
Sep 19, 2018
Actual Primary Completion Date :
Jan 15, 2020
Actual Study Completion Date :
Jan 15, 2020

Outcome Measures

Primary Outcome Measures

  1. Contraversive Pushing Scale score [4 weeks]

    Scale of evaluation of trunk control and pushing behavior in patients with stroke.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Must understand and voluntarily sign the corresponding informed consents and information sheet before any evaluation / procedure related to the study is conducted.

  • Male or female, ≥18 years of age at the time of consent.

  • Have the diagnosis of ischemic or hemorrhagic hemispheric stroke without excluding other causes (surgery, cancer, etc ...).

  • Enter for the first time in the Guadarrama Hospital to receive physiotherapy treatment.

Exclusion Criteria:
  • A patient can not be recruited in this study if they have severe cognitive impairment, moderate-severe language problems, or severe vision or hearing deficits that prevent compression and active collaboration during evaluation tests.

Contacts and Locations

Locations

Site City State Country Postal Code
1 J.Nicolas Cuenca Zaldivar Guadarrama Madrid Spain 28440

Sponsors and Collaborators

  • Guadarrama Hospital
  • Universidad Francisco de Vitoria

Investigators

  • Principal Investigator: J.Nicolas Cuenca Zaldivar, Guadarrama Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
J. Nicolas Cuenca Zaldivar, Rehabilitation Service Principal Investigator, Guadarrama Hospital
ClinicalTrials.gov Identifier:
NCT03674268
Other Study ID Numbers:
  • 4.0
First Posted:
Sep 17, 2018
Last Update Posted:
Feb 12, 2020
Last Verified:
Oct 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Feb 12, 2020